Advanced Search
LIU Runtian, AN Congjing, BAI Yun, ZHENG Jianxing. Effects of GSTP1 on Proliferation and Invasion of Human HepG2 Cells[J]. Cancer Research on Prevention and Treatment, 2016, 43(12): 1039-1042. DOI: 10.3971/j.issn.1000-8578.2016.12.006
Citation: LIU Runtian, AN Congjing, BAI Yun, ZHENG Jianxing. Effects of GSTP1 on Proliferation and Invasion of Human HepG2 Cells[J]. Cancer Research on Prevention and Treatment, 2016, 43(12): 1039-1042. DOI: 10.3971/j.issn.1000-8578.2016.12.006

Effects of GSTP1 on Proliferation and Invasion of Human HepG2 Cells

More Information
  • Received Date: March 28, 2016
  • Revised Date: June 22, 2016
  • Available Online: February 04, 2024
  • Objective 

    To investigate the effect of GSPT1 overexpression or knockdown on the proliferation and invasion of human HepG2 cells.

    Methods 

    HepG2 cells were infected with adenovirus (Ad)-GSTP- or Ad-shGSTP1 to overexpress or knockdown the expression of GSTP1 in HepG2 cells. The expression level of GSTP1 mRNA was examined by quantitative PCR; CCK-8 and Transwell assay were used to determine the cell viability and invasion, respectively. The expression of Akt, mTOR, p-Akt and p-mTOR were detected by Western blot.

    Results 

    The mRNA expression of GSTP1 was up-regulated after infection with Ad-GSTP1, and was down-regulated after infection with Ad-shGSTP1(P<0.05). The overexpression of GSTP1 significantly inhibited the viability and invasion of HepG2 cells(P<0.05), however, the knockdown of GSTP1 enhanced cell viability and invasion(P<0.05). Moreover, the phosphorylation level of Akt and mTOR were increased in the cells infected with Ad-GSTP1(P<0.05). Inverse results were obtained in the cells infected with Ad-shGSTP1.

    Conclusion 

    The viability and invasion of HepG2 cells could be inhibited by GSTP1 overexpression while enhanced by GSTP1 knockdown, which may be related with Akt/mTOR pathway.

  • [1]
    Guven M, Unal S, Erhan D, et al. Role of glutathione S-transferase M1, T1 and P1 gene polymorphisms in childhood acute lymphoblastic leukemia susceptibility in a Turkish population [J]. Meta Gene, 2015, 5: 115-9.
    [1]
    Guven M, Unal S, Erhan D, et al. Role of glutathione S-transferase M1, T1 and P1 gene polymorphisms in childhood acute lymphoblastic leukemia susceptibility in a Turkish population[J]. Meta Gene, 2015, 5: 115-9. doi: 10.1016/j.mgene.2015.06.002
    [2]
    Kassogue Y, Dehbi H, Quachouh M, et al. Association of glutathione S-transferase (GSTM1 and GSTT1) genes with chronic myeloid leukemia[J]. Springerplus, 2015, 4: 210.
    [2]
    Kassogue Y, Dehbi H, Quachouh M, et al. Association of glutathione S-transferase (GSTM1 and GSTT1) genes with chronic myeloid leukemia[J]. Springerplus, 2015, 4: 210. doi: 10.1186/s40064-015-0966-y
    [3]
    Wang Y, Ren BU, Zhang L, et al. Correlation between metabolic enzyme GSTP1 polymorphisms and susceptibility to lung cancer[J]. Exp Ther Med, 2015, 10(4): 1521-7.
    [3]
    Wang Y, Ren BU, Zhang L, et al. Correlation between metabolic enzyme GSTP1 polymorphisms and susceptibility to lung cancer[J]. Exp Ther Med, 2015, 10(4): 1521-7. http://cn.bing.com/academic/profile?id=f1d279fce3723e50410fe4af507144b5&encoded=0&v=paper_preview&mkt=zh-cn
    [4]
    Sun N, Sun X, Chen B, et al. MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer[J]. Cancer Chemother Pharmacol, 2010, 65(3): 437-46.
    [4]
    Sun N, Sun X, Chen B, et al. MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer[J]. Cancer Chemother Pharmacol, 2010, 65(3): 437-46. doi: 10.1007/s00280-009-1046-1
    [5]
    钟山亮, 蒋胜高, 唐金海, 等. 谷胱甘肽S转移酶基因多态性与乳腺癌化疗疗效的关系[J]. 临床检验杂志, 2010, 28(6): 438-4. http://www.cnki.com.cn/Article/CJFDTOTAL-LCJY201006015.htm

    Zhong SL, Jiang SG, Tang JH, et al. Association of GSTs gene polymorphism with reponse to chemotherapy in breast cancer[J]. Lin Chuang Jian Yan Za Zhi, 2010, 28(6): 438-4. http://www.cnki.com.cn/Article/CJFDTOTAL-LCJY201006015.htm
    [5]
    钟山亮, 蒋胜高, 唐金海, 等. 谷胱甘肽S转移酶基因多态性与 乳腺癌化疗疗效的关系[J]. 临床检验杂志, 2010, 28(6): 438-4. [Zhong SL, Jiang SG, Tang JH, et al. Association of GSTs gene polymorphism with reponse to chemotherapy in breast cancer[J]. Lin Chuang Jian Yan Za Zhi, 2010, 28(6): 438-4.]
    [6]
    Kwom DD, Lee JW, Han DY, et al. Relationship between the glutathione-S-transferase P1, M1, and T1 genotypes and prostate cancer risk in korean subjects[J]. Korean J Urol, 2011, 52(4): 247-52.
    [6]
    Kwom DD, Lee JW, Han DY, et al. Relationship between the glutathione-S-transferase P1, M1, and T1 genotypes and prostate cancer risk in korean subjects[J]. Korean J Urol, 2011, 52(4): 247-52. doi: 10.4111/kju.2011.52.4.247
    [7]
    赵艳姣. GSTM1、GSTT1和GSTP1基因多态性与乳腺癌临床病理特征、化疗疗效及毒性的研究[D]. 宁夏医科大学, 2014.

    Zhao YJ. The research of the relationship between the polymorphisms of GSTM1, GSTT1 and GSTP1 with cliniopathology features, chemotherapy response and toxicities in breast cancer[D]. Ningxia Yi Ke Da Xue, 2014.
    [7]
    赵艳姣. GSTM1、GSTT1和GSTP1基因多态性与乳腺癌 临床病理特征、化疗疗效及毒性的研究[D]. 宁夏医科大 学, 2014. [Zhao YJ. The research of the relationship between the polymorphisms of GSTM1, GSTT1 and GSTP1 with cliniopathology features, chemotherapy response and toxicities in breast cancer[D]. Ningxia Yi Ke Da Xue, 2014.]
    [8]
    苏成豪. 厦门地区HBV感染、环境因素及基因多态性与原发性肝癌的关联研究[D]. 福建医科大学, 2015.

    Su CH. The association study between HBV infection, environmental factors, polymorphisms and the risk of heptatocellular carcinoma in Xiamen[D]. Fujian Yi Ke Da Xue, 2015.
    [8]
    苏成豪. 厦门地区HBV感染、环境因素及基因多态性与原 发性肝癌的关联研究[D]. 福建医科大学, 2015. [Su CH. The association study between HBV infection, environmental factors, polymorphisms and the risk of heptatocellular carcinoma in Xiamen[D]. Fujian Yi Ke Da Xue, 2015.]
    [9]
    Orlewski J, Orlewska E. Effects of genetic polymorphisms of glutathione S-transferase genes (GSTM1, GSTT1, GSTP1) on the risk of diabetic nephropathy: a meta-analysis[J]. Pol Arch Med Wewn, 2015, 125(9): 649-58.
    [9]
    Orlewski J, Orlewska E. Effects of genetic polymorphisms of glutathione S-transferase genes (GSTM1, GSTT1, GSTP1) on the risk of diabetic nephropathy: a meta-analysis[J]. Pol Arch Med Wewn, 2015, 125(9): 649-58. http://cn.bing.com/academic/profile?id=4809e34f1c7eb01ca9db2f2610eab960&encoded=0&v=paper_preview&mkt=zh-cn
    [10]
    Shaban NZ, Salem HH, Elsadany MA, et al. Distribution of Glutathione S-Transferase Omega Gene Polymorphism with Different Stages of HBV Infection Including Hepatocellular Carcinoma in the Egyptian Population[J]. Asian Pac J Cancer Prev, 2016, 17(4): 2145-50. doi: 10.7314/APJCP.2016.17.4.2145
    [10]
    Shaban NZ, Salem HH, Elsadany MA, et al. Distribution of Glutathione S-Transferase Omega Gene Polymorphism with Different Stages of HBV Infection Including Hepatocellular Carcinoma in the Egyptian Population[J]. Asian Pac J Cancer Prev, 2016, 17(4): 2145-50.
    [11]
    Li CG, Zhao ZM, Hu MG, et al. Predictive role of glutathione-S transferase gene polymorphisms in risk and prognosis of hepatocellular carcinoma Asian[J]. Asian Pac J Cancer Prev, 2012, 13(7): 3247-52.
    [11]
    Li CG, Zhao ZM, Hu MG, et al. Predictive role of glutathione-S transferase gene polymorphisms in risk and prognosis of hepatocellular carcinoma Asian[J]. Asian Pac J Cancer Prev, 2012, 13(7): 3247-52. doi: 10.7314/APJCP.2012.13.7.3247
    [12]
    廖明娟, 陈红风. PI3K/Akt/mTOR信号通路抑制剂在乳腺癌中 的研究进展[J]. 中华肿瘤防治杂志, 2012, 19(3): 230-4. [Liao MJ, Chen HF, Targeted therapy on PI3K/Akt/mTOR signaling pathway in breast cancer[J]. Zhonghua Zhong Liu Fang Zhi Za Zhi, 2012, 19(3): 230-4.]
    [12]
    Liao MJ, Chen HF, Targeted therapy on PI3K/Akt/mTOR signaling pathway in breast cancer[J]. Zhonghua Zhong Liu Fang Zhi Za Zhi, 2012, 19(3): 230-4.
    [13]
    翟纯刚, 季晓平, 王和峰, 等. 抑制PI3K/Akt/mTOR信号通路对兔原代巨噬细胞自体吞噬的影响及机制[J]. 中国动脉硬化杂志, 2014, 22(1): 7-12. http://www.cnki.com.cn/Article/CJFDTOTAL-KDYZ201401002.htm

    Zhai CG, Ji XP, Wang HF, et al. Roles of selective inhibition of PI3K/Akt/mTOR signaling pathway on rabbit primary macrophage autophagy and possible pechnism[J]. Zhongguo Dong Mai Ying Hua Za Zhi, 2014, 22(1): 7-12. http://www.cnki.com.cn/Article/CJFDTOTAL-KDYZ201401002.htm
    [13]
    翟纯刚, 季晓平, 王和峰, 等. 抑制PI3K/Akt/mTOR信号通路 对兔原代巨噬细胞自体吞噬的影响及机制[J]. 中国动脉硬化 杂志, 2014, 22(1): 7-12. [Zhai CG, Ji XP, Wang HF, et al. Roles of selective inhibition of PI3K/Akt/mTOR signaling pathway on rabbit primary macrophage autophagy and possible pechnism[J]. Zhongguo Dong Mai Ying Hua Za Zhi, 2014, 22(1): 7-12.]
    [14]
    Li J, Huang S, Zhang J, et al. Mesenchymal stem cells ameliorate inflammatory cytokine-induced impairment of AT-II cells through a keratinocyte growth factor-dependent PI3K/Akt/mTOR signaling pathway[J]. Mol Med Rep, 2016, 13(5): 3755-62. http://cn.bing.com/academic/profile?id=0def8fe9c6c6d5299700ef9e35b96cdd&encoded=0&v=paper_preview&mkt=zh-cn
    [14]
    Li J, Huang S, Zhang J, et al. Mesenchymal stem cells ameliorate inflammatory cytokine-induced impairment of AT-II cells through a keratinocyte growth factor-dependent PI3K/Akt/mTOR signaling pathway[J]. Mol Med Rep, 2016, 13(5): 3755-62.
  • Related Articles

    [1]YAN Rui, XIAO Zeru, HUANG Xuying, AN Guangyu, GE Yang. DCLK1 Promotes Malignancy of A549 Cell Line by Activating FAK/PI3K/AKT/mTOR Pathway[J]. Cancer Research on Prevention and Treatment, 2024, 51(6): 419-425. DOI: 10.3971/j.issn.1000-8578.2024.23.1355
    [2]HAN Jibo, HUANG Maoling, SHEN Lijun, CHEN Shiming, TAO Zezhang. miR-214 Inhibits Apoptosis of Nasopharyngeal Carcinoma Cells by Activating AKT Signaling Pathway Through Targeting PTEN[J]. Cancer Research on Prevention and Treatment, 2020, 47(10): 734-739. DOI: 10.3971/j.issn.1000-8578.2020.20.0149
    [3]SUN Yuanyuan, ZHANG Mingzhi. Research Progress on PI3K/AKT/mTOR Signaling Pathway in Burkitt Lymphoma[J]. Cancer Research on Prevention and Treatment, 2019, 46(2): 169-173. DOI: 10.3971/j.issn.1000-8578.2019.18.0818
    [4]TANG Hua, FENG Hao, XIAO Weirong, LIAO Yangying, LI Lan, XU Xiaopeng, YAN Xiaohan. MCM7 Knockdown Inhibits Migration and Invasion While Induces Apoptosis of Cutaneous Malignant Melanoma Cells Through AKT Signaling Pathway[J]. Cancer Research on Prevention and Treatment, 2018, 45(10): 739-745. DOI: 10.3971/j.issn.1000-8578.2018.18.0318
    [5]ZHANG Xin, LIN Yu, HAI Long, LI Tao, ZHANG Chen. NOTCH Signaling Pathway Regulates Glioma Stem-like Cell Proliferation and Self-renewal Abilities via PI3K/AKT Activity[J]. Cancer Research on Prevention and Treatment, 2018, 45(9): 640-646. DOI: 10.3971/j.issn.1000-8578.2018.18.0029
    [6]NAN Zhenhua, PAN Linghui. Mechanism of Ibuprofen Regulating Migration and Invasion of Liver Cancer QGY-7703 Cells Through PI3K/Akt/mTOR Signaling Pathway[J]. Cancer Research on Prevention and Treatment, 2016, 43(12): 1035-1038. DOI: 10.3971/j.issn.1000-8578.2016.12.005
    [7]HU Li’na, PENG Xingchun, GUO Xianzhi, LIU Hui, LONG Zhiguo, YU Minghua. Effects on Cell Proliferation, Invasion and Migration of Esophageal Adenocarcinoma by Inhibition of Notch and PI3K /Akt Pathway[J]. Cancer Research on Prevention and Treatment, 2016, 43(8): 653-658. DOI: 10.3971/j.issn.1000-8578.2016.08.001
    [8]ZHAO Jingjing, DAI Xiaojun, ZHANG Xiaochun. Role of Akt-mediated Signaling Pathways in Tumor Lymphangiogenesis[J]. Cancer Research on Prevention and Treatment, 2016, 43(5): 422-426. DOI: 10.3971/j.issn.1000-8578.2016.05.22
    [9]ZENG Bo-hang, ZHUANG Ying, CHEN Jing-qi, JIANG Su-hua, ZENG Mu-sheng. Effects of Rapamycin on Expression of mTOR Signaling Pathway Relative Protein in Lung Cancer Cell[J]. Cancer Research on Prevention and Treatment, 2011, 38(10): 1105-1108. DOI: 10.3971/j.issn.1000-8578.2011.10.003
    [10]LIU Hong, FANG Zhao-hui, FAN Xiao-mei, LI Kui-xiu, WU Xiao-hua. LPA Inhibits Apoptosis Induced by Cisplatin in Ovarian Carcinoma Cells via PI3K/Akt Signaling Pathway[J]. Cancer Research on Prevention and Treatment, 2010, 37(01): 34-38. DOI: 10.3971/j.issn.1000-8578.2010.01.010

Catalog

    Article views (1429) PDF downloads (627) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return